TP-021 |
TP-021 : Inhibitor of BCL6
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| BCL6 |
|
|
Inhibitor
1-10 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
TP-021 and TP-021n show no significant inhibition at 1 μM in Takeda in house kinase panel (344 targe ...
Potency Cellular
In Vitro
BCL6
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.bmc.2017.07.037
In Vivo Validations
Mouse
Dose: 0.1 mg/kg IV, 1 mg/kg PO
Route of delivery:
Oral, Intravenous
Systemic clearance:
630 mL/h*Kg
Cmax:
233 ng/mL
Tmax:
2.0 h
Area Under the Curve::
1.27 ug*h/mL
Bioavailability:
79.9%
Volume of Distribution at Steady-State:
1505 mL/Kg
DOI Reference: 10.1016/j.bmc.2017.07.037
Negative Control Compounds
Chemical Information
| Molecular Formula | C20H20ClN3O5 |
| SMILEs | O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1 |
| InChI | InChI=1S/C20H20ClN3O5/c21-15-10-18(24(26)27)19(29-14-5-7-28-8-6-14)11-17(15)22-13-2-3-16-12(9-13)1-4-20(25)23-16/h2-3,9-11,14,22H,1,4-8H2,(H,23,25) |
| Molecular weight | 417.11 Da |
| AlogP | 4.434300000000003 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 49 |